KILITCH DRUGS INDIA LTD (KILITCH)

NSE: ₹177.84
BSE: ₹179.00
Stock Performance
Corporate Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance

We are hereby submitting annual secretarial compliance report for the year ended 31st March, 2026

2026-05-27 11:34:16
Announcement under Regulation 30 (LODR)-Newspaper Publication

We are submitting hereby copy of newspaper publication of the extract of financial results for the quarter ended 31st March, 2026

2026-05-18 17:38:52
Board Meeting Outcome for Submission Of Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St March, 2026

We are hereby submitting audited standalone and consolidated financial results of the Company for the quarter ended 31st March, 2026

2026-05-15 19:11:45
Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St March, 2026

We are hereby submitting audited standalone and consolidated financial results for the quarter ended 31st March, 2026

2026-05-15 19:05:46
Announcement under Regulation 30 (LODR)-Monitoring Agency Report

We are hereby submitting the monitoring agency report for the quarter ended 31st March, 2026

2026-05-15 18:49:13
Board Meeting Intimation for Considering And Approval Of The Audited Financial Results For The Quarter And Year Ended 31St March 2026

the audited financial results (standalone and consolidated) of the Company for the quarter and year ended 31st March, 2026

2026-05-07 11:51:13
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are hereby submitting certificate under regulation 74(5) of SEBI (DP) Regulations received from MUFG Intime India Private Limited, RTA of the Company

2026-04-14 13:38:38
Board Meeting Outcome for Allotment Of Bonus Equity Shares

Board approved the allotment of bonus equity shares in the ratio of 1:1

2026-03-25 12:20:27
Closure of Trading Window

Closure of Trading Window

2026-03-25 09:50:35
Intimation Of Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

We hereby inform you that the Company has fixed Tuesday, 24th March, 2026 as record date in order to determine the number of shareholders entitled for bonus equity shares in the ratio of 1:1

2026-03-17 15:20:52

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 31.12 31.57 29.77 39.14 33.42 45.35 46.51 56.30 34.12 37.81 44.67 71.97
YOY Revenue Growth % 32.06% 40.77% 4.43% -9.58% 7.38% 43.63% 56.27% 43.87% 2.1% -16.62% -3.96% 27.82%
Other Income 0.98 0.92 3.40 0.90 3.21 5.81 2.37 2.32 3.50 7.61 1.61 1.14
Total Income 32.10 32.49 33.16 40.03 36.63 51.16 48.88 58.63 37.62 45.42 46.28 73.11
Total Expenses + 26.52 26.56 26.58 34.77 31.04 40.58 39.36 43.63 31.64 35.35 40.11 53.78
Cost of Materials Consumed 13.67 15.34 14.91 22.41 18.62 22.95 24.50 27.13 18.27 15.68 25.32 28.53
Employee Benefit Expense 1.97 2.00 2.03 1.91 2.22 2.49 2.73 2.58 2.40 3.28 3.04 3.61
Other Expenses 9.94 8.86 8.53 9.94 9.47 14.15 10.94 14.14 10.65 13.11 12.29 18.88
Operating Profit 4.60 5.01 3.19 4.36 2.38 4.77 7.15 12.67 2.49 2.47 4.56 18.19
OPM % 14.8% 15.9% 10.7% 11.1% 7.1% 10.5% 15.4% 22.5% 7.3% 6.5% 10.2% 25.3%
Profit Before Tax + 5.58 5.93 6.58 5.26 5.59 10.58 9.52 15.00 5.98 10.07 6.17 19.33
Tax Expense 1.39 1.69 1.08 1.62 1.54 1.73 2.64 3.62 1.19 1.36 1.28 5.33
Tax % 24.9% 28.5% 16.4% 30.7% 27.5% 16.4% 27.7% 24.2% 19.9% 13.5% 20.7% 27.6%
Profit After Tax 4.19 4.24 5.50 3.64 4.05 8.85 6.88 11.37 4.79 8.72 4.89 14.00
EPS (Basic) 2.69 2.60 3.48 2.26 2.52 5.50 4.28 7.07 2.98 5.27 2.74 4.08

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 188.57 181.59 131.60 117.78 105.16 70.02 60.77
YOY Revenue Growth % 3.85% 37.99% 11.73% 12% 50.19% 15.22% -
Other Income 13.85 13.72 6.19 4.60 4.56 4.19 5.71
Total Income 202.42 195.30 137.79 122.38 109.72 74.21 66.48
Total Expenses + 160.87 154.61 114.43 102.93 95.79 66.70 60.12
Cost of Materials Consumed 87.80 93.19 66.33 58.27 60.29 37.97 36.49
Employee Benefit Expense 12.34 10.03 7.91 7.47 6.15 5.22 5.65
Other Expenses 54.93 48.70 37.15 34.65 27.77 20.53 17.98
Operating Profit 27.71 26.97 17.16 14.85 9.37 3.31 0.65
OPM % 14.7% 14.9% 13% 12.6% 8.9% 4.7% 1.1%
Profit Before Exceptional 41.55 40.69 23.35 19.45 13.93 7.51 5.22
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 41.55 40.69 23.35 19.45 13.93 7.51 5.22
Tax Expense 9.15 9.53 5.78 3.73 3.40 1.35 0.77
Tax % 22% 23.4% 24.7% 19.2% 24.4% 18% 14.7%
Profit After Tax 32.40 31.16 17.57 15.72 10.53 6.16 4.46
EPS (Basic) 9.57 19.37 11.03 10.09 6.76 3.98 2.89

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 293.31 195.78 145.98 137.65 134.57 124.09 0.00
Property, Plant & Equipment 19.27 19.16 15.26 14.82 13.95 6.79 0.00
Capital Work in Progress 140.02 47.29 5.97 1.31 0.00 0.00 0.00
Non-Current Investments 71.89 71.85 71.27 71.10 70.15 70.10 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.26 0.35 0.44 0.26 0.23 0.15 0.00
Current Assets + 206.14 162.38 141.49 114.77 97.72 71.76 0.00
Inventories 11.52 15.31 3.99 2.04 5.00 3.59 0.00
Trade Receivables 117.24 83.40 61.80 53.10 41.42 22.92 0.00
Cash and Cash Equivalents 9.30 7.41 17.95 17.84 2.45 5.77 0.00
Current Investments 51.96 49.52 49.43 39.20 47.23 36.40 0.00
LIABILITIES & EQUITY
Total Equity 333.01 252.94 222.92 195.93 178.03 162.93 0.00
Equity Share Capital 34.96 16.08 16.08 15.58 15.58 15.49 0.00
Other Equity 298.05 236.86 206.84 180.35 162.45 147.44 0.00
Non-Current Liabilities 59.28 28.02 0.17 0.07 0.28 0.38 0.00
Current Liabilities 107.17 77.20 64.37 56.42 53.99 32.53 0.00
Total Liabilities 166.45 105.21 64.55 56.49 54.26 32.91 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 12.32 15.23 -1.19 6.10 5.21 6.88 0.00
Cash from Investing Activities -96.00 -41.42 -10.10 6.24 -16.08 -5.35 0.00
Cash from Financing Activities 85.57 15.65 11.40 3.04 7.55 1.52 0.00
Net Increase/Decrease in Cash 1.89 -10.54 0.11 15.39 2.45 3.05 0.00